Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   HTML views PDF downloads Totals
30,026 Dovepress* 26,947+ 1,329 28,276
PubMed Central* 3,079 663 3,742
Totals 30,026 1,992 32,018
*Since 24 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 0 6 11

View citations on PubMed Central and Google Scholar